NASDAQ: APVO
Aptevo Therapeutics Inc Stock Ownership - Who owns Aptevo Therapeutics?

Insider buying vs selling

Have Aptevo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Grady Grant IiiDirector2025-11-1013,513$1.49
$20.13kBuy

1 of 1

APVO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APVO insiders and whales buy or sell their stock.

APVO Shareholders

What type of owners hold Aptevo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri17.93%3,021,899$3.23MInsider
Point72 Asset Management LP1.78%299,944$320.94kInstitution
Scott C. Stromatt1.28%216,183$231.32kInsider
Drw Securities LLC0.78%131,480$140.68kInstitution
Jane A. Gross0.65%109,583$117.25kInsider
Shawnte Mitchell0.48%80,527$86.16kInsider
Randy Joe Maddux0.45%75,000$80.25kInsider
Michael Adelman0.42%70,426$75.36kInsider
Virtu Financial LLC0.23%38,282$40.96kInstitution
Grady Grant Iii0.08%13,514$14.46kInsider

1 of 3

APVO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APVO2.93%21.29%Net BuyingNet Buying
APLT65.67%8.55%Net SellingNet Selling
LSTA0.84%99.16%Net Selling
KAPA2.14%35.55%
CTXR3.67%3.32%

Aptevo Therapeutics Stock Ownership FAQ

Who owns Aptevo Therapeutics?

Aptevo Therapeutics (NASDAQ: APVO) is owned by 2.93% institutional shareholders, 21.29% Aptevo Therapeutics insiders, and 75.78% retail investors. Fuad Elhibri is the largest individual Aptevo Therapeutics shareholder, owning 3.02M shares representing 17.93% of the company. Fuad Elhibri's Aptevo Therapeutics shares are currently valued at $3.23M.

If you're new to stock investing, here's how to buy Aptevo Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.